The SEC is currently investigating if the company violated securities law by allegedly fabricating payments for phantom nursing shifts at its London subsidiary. The company denies the allegation.
If the equity firm moves forward with possible plans for an initial public offering during the investigation, the company would be required to disclose that information, which may or may not deter investors from purchasing the stock.
According an analyst interviewed in the report, the investigation will be most likely to affect the timing of the IPO.
Read The Tennessean‘s report on the possible HCA IPO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
